Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.

Br J Cancer · 1996 · PMC2074489 · PMID 8645587

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

likely to be significantno p-value reported

First, we recognise that other enzymes of the aspartyl, cysteine and serine proteinase families and their specific inhibitors are also likely to be significant participants in ECM remodelling during cancer progression.

also in 891 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.